Data / Form D filings / Inmedix, Inc.
Inmedix, Inc.: Form D filing
Inmedix, Inc., a biotechnology company in Normandy Park, WA, filed a Form D with the SEC in 2026. The latest, on October 22, 2026, reports $4 million sold of a $5 million offering to 34 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17837 FIRST AVENUE SOUTH, #6, Normandy Park, WA, 98148
- Phone
- (206) 412-5347
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1851853
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22 | Amendment | $5,000,000 | $4,009,945 | $990,055 | 34 | Sep 24 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Holman, M.D. | Executive Officer, Director | |
| Steven Daly, M.S., M.B.A. | Director | |
| Bernie Tobin | Director | |
| Leroy Hood, M.D., Ph.D. | Director | |
| Kevin Tracey, M.D. | Director | |
| Ryan Sullivan, Ph.D. | Director |
Every Form D from the week of Oct 19 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Inmedix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.